Related Experiment Video
Updated: Feb 3, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
Published on: December 22, 2023
Mice harboring an MCTO mutation exhibit renal failure resembling nephropathy in human patients
Yuki Tsunakawa1,2, Michito Hamada1,3, Yurina Matsunaga1
1Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
Abstract:
Multicentric carpotarsal osteolysis (MCTO) is a condition involving progressive osteolysis of the carpal and tarsal bones that is associated with glomerular sclerosis and renal failure (MCTO nephropathy). Previous work identified an autosomal dominant missense mutation in the transactivation domain of the transcription factor MAFB as the cause of MCTO. Several methods are currently used for MCTO nephropathy treatment, but these methods are invasive and lead to severe side effects, limiting their use. Therefore, the development of alternative treatments for MCTO nephropathy is required; however, the pathogenesis of MCTO in vivo is unclear without access to a mouse model. Here, we report the generation of an MCTO mouse model using the CRISPR/Cas9 system. These mice exhibit nephropathy symptoms that are similar to those observed in MCTO patients. MafbMCTO/MCTO mice show developmental defects in body weight from postnatal day 0, which persist as they age. They also exhibit high urine albumin creatinine levels from a young age, mimicking the nephropathic symptoms of MCTO patients. Characteristics of glomerular sclerosis reported in human patients are also observed, such as histological evidence of focal segmental glomerulosclerosis (FSGS), podocyte foot process microvillus transformation and podocyte foot process effacement. Therefore, this study contributes to the development of an alternative treatment for MCTO nephropathy by providing a viable mouse model.
Insights
Researchers developed a mouse model for multicentric carpotarsal osteolysis (MCTO) nephropathy using CRISPR/Cas9. This model replicates human symptoms, aiding the search for new treatments for this rare bone and kidney disease.
Area of Science:
- Genetics and Molecular Biology
- Nephrology
- Skeletal Biology
Background:
- Multicentric carpotarsal osteolysis (MCTO) is a rare genetic disorder characterized by progressive bone loss in the wrists and ankles.
- MCTO is frequently associated with kidney disease, termed MCTO nephropathy, leading to glomerular sclerosis and renal failure.
- A specific autosomal dominant mutation in the MAFB gene has been identified as the cause of MCTO.
Purpose of the Study:
- To establish a viable mouse model for studying the in vivo pathogenesis of MCTO nephropathy.
- To provide a preclinical tool for the development of novel therapeutic strategies for MCTO nephropathy.
- To investigate the effects of the Mafb mutation on kidney development and function.
Main Methods:
- Utilized the CRISPR/Cas9 gene-editing system to introduce a specific Mafb mutation into the mouse genome.
- Phenotypically characterized the generated Mafb mutant mice (MafbMCTO/MCTO) from birth.
- Assessed kidney function through urine albumin-to-creatinine ratio measurements and performed histological analysis of kidney tissues.
Main Results:
- MafbMCTO/MCTO mice displayed reduced body weight from birth, persisting throughout aging.
- Elevated urine albumin-to-creatinine levels were observed in young mutant mice, indicating significant nephropathy.
- Histological examination revealed focal segmental glomerulosclerosis (FSGS), podocyte foot process effacement, and microvillus transformation, mirroring human MCTO nephropathy.
Conclusions:
- The generated MafbMCTO/MCTO mouse model accurately recapitulates the key features of human MCTO nephropathy.
- This mouse model serves as a crucial platform for understanding MCTO pathogenesis and for testing potential treatments.
- The study facilitates the advancement of therapeutic interventions for patients suffering from this debilitating condition.
More Related Videos
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
04:01Author Spotlight: Modeling Brain Tumors In Vivo Using Electroporation-Based Delivery of Plasmid DNA Representing Patient Mutation Signatures
Published on: June 23, 2023
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Mutations in Microorganisms